{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:59:25Z","timestamp":1774306765814,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hainan Medical University Academic Enhancement Support Program","award":["XSTS2025001"],"award-info":[{"award-number":["XSTS2025001"]}]},{"name":"National Clinical Key Speciality Capacity Building Project","award":["202330"],"award-info":[{"award-number":["202330"]}]},{"name":"Hainan Province Clinical Medical Center","award":["2021818"],"award-info":[{"award-number":["2021818"]}]},{"name":"Specific Research Fund of The Innovation Platform for Academicians of Hainan Province","award":["YSPTZX202313"],"award-info":[{"award-number":["YSPTZX202313"]}]},{"name":"Joint Project on Health Science and Technology Innovation in Hainan Province","award":["SQ2023WSJK0301"],"award-info":[{"award-number":["SQ2023WSJK0301"]}]},{"name":"Hainan Province Education Reform Project","award":["hnjg2024-67"],"award-info":[{"award-number":["hnjg2024-67"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45173-1","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T14:33:52Z","timestamp":1774190032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current status survey and risk factor analysis of metabolic dysfunction-associated steatotic liver disease among adolescents in Hainan Province"],"prefix":"10.1038","volume":"16","author":[{"given":"Shuo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-ting","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjiao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qicen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-6131","authenticated-orcid":false,"given":"Feihu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"issue":"1","key":"45173_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.clnu.2023.11.001","volume":"43","author":"J Ji","year":"2024","unstructured":"Ji, J. et al. Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children. Clin. Nutr. 43 (1), 187\u2013196 (2024).","journal-title":"Clin. Nutr."},{"issue":"3","key":"45173_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ecl.2023.01.003","volume":"52","author":"SD Anwar","year":"2023","unstructured":"Anwar, S. D., Foster, C. & Ashraf, A. Lipid Disorders and Metabolic-Associated Fatty Liver Disease. Endocrinol. Metab. Clin. North. Am. 52 (3), 445\u2013457 (2023).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"3","key":"45173_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ecl.2023.02.003","volume":"52","author":"C Gofton","year":"2023","unstructured":"Gofton, C., Clark-Dickson, M. & George, J. Lean Metabolic-Associated Fatty Liver Disease. Endocrinol. Metab. Clin. North. Am. 52 (3), 431\u2013444 (2023).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"3","key":"45173_CR4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/molecules27030858","volume":"27","author":"MA Alshawsh","year":"2022","unstructured":"Alshawsh, M. A. et al. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet. Molecules 27 (3), 858 (2022).","journal-title":"Molecules"},{"issue":"12","key":"45173_CR5","doi-asserted-by":"publisher","first-page":"12966","DOI":"10.1111\/ijpo.12966","volume":"17","author":"M Oses","year":"2022","unstructured":"Oses, M. et al. Peripheral blood mononuclear cells-expressed miRNA profiles derived from children with metabolic-associated fatty liver disease and insulin resistance. Pediatr. Obes. 17 (12), 12966 (2022).","journal-title":"Pediatr. Obes."},{"issue":"3","key":"45173_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ecl.2023.01.001","volume":"52","author":"S Fouda","year":"2023","unstructured":"Fouda, S. et al. Pathobiology of Metabolic-Associated Fatty Liver Disease. Endocrinol. Metab. Clin. North. Am. 52 (3), 405\u2013416 (2023).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"4","key":"45173_CR7","first-page":"283","volume":"21","author":"A Sekkarie","year":"2018","unstructured":"Sekkarie, A., Welsh, J. A. & Vos, M. B. Carbohydrates and diet patterns in nonalcoholic fatty liver disease in children and adolescents. Curr. Opin. Clin. Nutr. Metab. Care. 21 (4), 283\u2013288 (2018).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"3","key":"45173_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ecl.2023.02.005","volume":"52","author":"C Mandato","year":"2023","unstructured":"Mandato, C., Panera, N. & Alisi, A. Pregnancy and Metabolic-Associated Fatty Liver Disease. Endocrinol. Metab. Clin. North. Am. 52 (3), 521\u2013531 (2023).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"5","key":"45173_CR9","first-page":"775","volume":"49","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Association of adipocytokine pathway gene polymorphisms with NAFLD in obese children. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 49 (5), 775\u2013783 (2024). English, Chinese.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"2","key":"45173_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jhep.2019.03.026","volume":"71","author":"L Youssefian","year":"2019","unstructured":"Youssefian, L. et al. Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations. J. Hepatol. 71 (2), 366\u2013370 (2019).","journal-title":"J. Hepatol."},{"issue":"3","key":"45173_CR11","doi-asserted-by":"publisher","first-page":"e16133","DOI":"10.1111\/liv.16133","volume":"45","author":"S Petta","year":"2025","unstructured":"Petta, S., Armandi, A. & Bugianesi, E. Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD [J]. Liver international: official J. Int. Association Study Liver. 45 (3), e16133(2025).","journal-title":"Liver international: official J. Int. Association Study Liver"},{"issue":"4","key":"45173_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3350\/cmh.2024.0268","volume":"30","author":"B Sun","year":"2024","unstructured":"Sun, B. et al. TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD [J]. Clin. Mol. Hepatol. 30 (4), 863\u2013882(2024).","journal-title":"Clin. Mol. Hepatol."},{"key":"45173_CR13","doi-asserted-by":"crossref","unstructured":"Chen, V. L. et al. Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatment [J]. J. Clin. Investig. 135 (7)(2025).","DOI":"10.1172\/JCI186424"},{"issue":"22","key":"45173_CR14","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.3390\/molecules29225245","volume":"29","author":"J Markowska","year":"2024","unstructured":"Markowska, J. et al. Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Molecules 29 (22), 5245 (2024).","journal-title":"Molecules"},{"key":"45173_CR15","doi-asserted-by":"publisher","first-page":"1447878","DOI":"10.3389\/fnut.2024.1447878","volume":"11","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Regulation of bile acids and their receptor FXR in metabolic diseases. Front. Nutr. 11, 1447878 (2024).","journal-title":"Front. Nutr."},{"key":"45173_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clnu.2025.01.019","volume":"46","author":"W Shi","year":"2025","unstructured":"Shi, W. et al. The associations between irregular breakfast and late-night snacking with metabolic dysfunction-associated steatotic liver disease. Clin. Nutr. 46, 52\u201359 (2025).","journal-title":"Clin. Nutr."},{"key":"45173_CR17","doi-asserted-by":"publisher","first-page":"1474384","DOI":"10.3389\/fendo.2024.1474384","volume":"15","author":"M Liu","year":"2025","unstructured":"Liu, M. et al. Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease among Chinese children with obesity. Front. Endocrinol. (Lausanne). 15, 1474384 (2025).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"45173_CR18","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/aogs.14816","volume":"103","author":"H de Ruyter","year":"2024","unstructured":"de Ruyter, H. et al. Maternal gestational hypertension, smoking and pre-eclampsia are associated with metabolic dysfunction-associated fatty liver disease in overweight offspring. Acta Obstet. Gynecol. Scand. 103 (6), 1183\u20131191 (2024).","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"9","key":"45173_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","volume":"16","author":"V Nobili","year":"2019","unstructured":"Nobili, V. et al. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat. Reviews Gastroenterol. Hepatol. 16 (9), 517\u2013530 (2019).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"issue":"3","key":"45173_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/apt.17096","volume":"56","author":"J Li","year":"2022","unstructured":"Li, J. et al. Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000\u20132021. Aliment. Pharmacol. Ther. 56 (3), 396\u2013406 (2022).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"9","key":"45173_CR21","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1111\/liv.15080","volume":"42","author":"Z-Y Zou","year":"2022","unstructured":"Zou, Z-Y. et al. The burden and sexual dimorphism with nonalcoholic fatty liver disease in Asian children: A systematic review and meta-analysis. Liver International: Official J. Int. Association Study Liver. 42 (9), 1969\u20131980 (2022).","journal-title":"Liver International: Official J. Int. Association Study Liver"},{"key":"45173_CR22","unstructured":"Results of the Seventh National Population Census in Hainan. Province Released Today\u2019s Hainan Hainan Provincial People\u2019s Government Website [EB\/OL]. [2025-02-10 https:\/\/www.hainan.gov.cn\/hainan\/5309\/202105\/3f73ddd69ce0461e9a07da826aa270eb.shtml"},{"key":"45173_CR23","unstructured":"Du Xiaohan. Analysis of the Current Development Situation of Homestays in Ethnic Minority-Populated Areas in Hainan Province - China National Knowledge Infrastructure (CNKI) [EB]. [2025-02-10]."},{"issue":"4","key":"45173_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s12072-023-10543-8","volume":"17","author":"XD Zhou","year":"2023","unstructured":"Zhou, X. D. et al. An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatol. Int. 17 (4), 773\u2013791 (2023).","journal-title":"Hepatol. Int."},{"issue":"2","key":"45173_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","volume":"19","author":"M Eslam","year":"2025","unstructured":"Eslam, M. et al. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatol. Int. 19 (2), 261\u2013301 (2025).","journal-title":"Hepatol. Int."},{"issue":"04","key":"45173_CR26","first-page":"339","volume":"33","author":"B Li Junxiang","year":"2025","unstructured":"Li Junxiang, B., Yuning, W., Yunliang, W. & Zhibin Expert Consensus on Integrated Traditional Chinese and Western Medicine for the Diagnosis and Treatment of Non-alcoholic Fatty Liver Disease (2025) [J]. Chin. J. Integr. Traditional Chin. Western Med. Digestion. 33 (04), 339\u2013350 (2025).","journal-title":"Chin. J. Integr. Traditional Chin. Western Med. Digestion"},{"issue":"8","key":"45173_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3349\/ymj.2024.0442","volume":"66","author":"K Song","year":"2025","unstructured":"Song, K. et al. Prediction Model for Insulin Resistance and Implications for MASLD in Youth: A Novel Marker, the Pediatric Insulin Resistance Assessment Score. Yonsei Med. J. 66 (8), 464\u2013472 (2025).","journal-title":"Yonsei Med. J."},{"key":"45173_CR28","doi-asserted-by":"publisher","first-page":"101717","DOI":"10.1016\/j.lanwpc.2025.101717","volume":"64","author":"X LI","year":"2025","unstructured":"LI, X. et al. Pediatric MASLD in China: epidemiology, screening, diagnosis, and management [J]. Lancet Reg. health Western Pac. 64, 101717(2025).","journal-title":"Lancet Reg. health Western Pac."},{"issue":"1","key":"45173_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.12997\/jla.2025.14.1.5","volume":"14","author":"Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease","year":"2025","unstructured":"Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. J. Lipid Atheroscler, 14(1): 5\u201329. (2025).","journal-title":"J. Lipid Atheroscler"},{"issue":"4","key":"45173_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/MPG.0000000000003024","volume":"72","author":"SL Noon","year":"2021","unstructured":"Noon, S. L. et al. Incidence of Depression and Anxiety in a Cohort of Adolescents With Nonalcoholic Fatty Liver Disease. J. Pediatr. Gastroenterol. Nutr. 72 (4), 579\u2013583 (2021).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"2","key":"45173_CR31","first-page":"64","volume":"115","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. Prevalence of non-alcoholic fatty liver disease in pediatric mental disorder inpatients: a tertiary mental health referral hospital study. Rev. Esp. Enferm Dig. 115 (2), 64\u201369 (2023).","journal-title":"Rev. Esp. Enferm Dig."},{"key":"45173_CR32","doi-asserted-by":"publisher","first-page":"1425024","DOI":"10.3389\/fendo.2024.1425024","volume":"15","author":"X Qian","year":"2025","unstructured":"Qian, X. et al. Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus. Front. Endocrinol. (Lausanne). 15, 1425024 (2025).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"45173_CR33","doi-asserted-by":"crossref","unstructured":"Shariq, A., Khan, S. & Usmani, S. U. R. The Role of Dietary Protein in Mitigating the Risk of Nonalcoholic Fatty Liver Disease. Nutr. Rev.83(8),1537-1539(2025).","DOI":"10.1093\/nutrit\/nuae229"},{"issue":"14","key":"45173_CR34","first-page":"2060","volume":"25","author":"Liu Yajun","year":"2014","unstructured":"Liu Yajun. Correlation Analysis of Blood Lipid, Adiponectin Level with Insulin Resistance and the Incidence of Fatty Liver in Simple Obese Children [J]. Hainan Med. J. 25 (14), 2060\u20132062 (2014).","journal-title":"Hainan Med. J."},{"issue":"3","key":"45173_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ecl.2023.02.004","volume":"52","author":"T Bali","year":"2023","unstructured":"Bali, T., Chrysavgis, L. & Cholongitas, E. Metabolic-Associated Fatty Liver Disease and Sarcopenia. Endocrinol. Metab. Clin. North. Am. 52 (3), 497\u2013508 (2023).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"45173_CR36","doi-asserted-by":"crossref","unstructured":"Jones, R. B. et al. PNPLA3 Genotype, Arachidonic Acid Intake, and Unsaturated Fat Intake Influences Liver Fibrosis in Hispanic Youth with Obesity. Nutrients. 13(5), 1621 (2023).","DOI":"10.3390\/nu13051621"},{"issue":"14","key":"45173_CR37","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3390\/nu16142220","volume":"16","author":"M Beygi","year":"2024","unstructured":"Beygi, M. et al. Management of Metabolic-Associated Fatty Liver Disease\/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions. Nutrients 16 (14), 2220 (2024).","journal-title":"Nutrients"},{"key":"45173_CR38","doi-asserted-by":"publisher","first-page":"603654","DOI":"10.3389\/fped.2020.603654","volume":"8","author":"YC Lin","year":"2020","unstructured":"Lin, Y. C., Wu, C. C. & Ni, Y. H. New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease. Front. Pediatr. 8, 603654 (2020).","journal-title":"Front. Pediatr."},{"key":"45173_CR39","doi-asserted-by":"crossref","unstructured":"Nehaoua, A. et al. Lipid Biochemistry and its Role in Human Diseases (Curr Med Chem, 2025).","DOI":"10.2174\/0109298673351452241220071215"},{"key":"45173_CR40","doi-asserted-by":"publisher","first-page":"1436827","DOI":"10.3389\/fendo.2024.1436827","volume":"15","author":"Z Zheng","year":"2025","unstructured":"Zheng, Z. et al. Role of plasma metabolome in mediating the effect of plasma lipidome on NAFLD: a Mendelian randomization study. Front. Endocrinol. (Lausanne). 15, 1436827 (2025).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"45173_CR41","doi-asserted-by":"publisher","first-page":"785819","DOI":"10.3389\/fendo.2022.785819","volume":"13","author":"S Le Lay","year":"2022","unstructured":"Le Lay, S., Magr\u00e9, J. & Prieur, X. Not Enough Fat: Mouse Models of Inherited Lipodystrophy. Front. Endocrinol. (Lausanne). 13, 785819 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"45173_CR42","doi-asserted-by":"publisher","first-page":"102866","DOI":"10.1016\/j.ebiom.2020.102866","volume":"57","author":"M Meroni","year":"2020","unstructured":"Meroni, M. et al. .MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD. EbioMedicine 57, 102866 (2020).","journal-title":"EbioMedicine"},{"key":"45173_CR43","doi-asserted-by":"publisher","first-page":"1451898","DOI":"10.3389\/fpubh.2024.1451898","volume":"12","author":"AT Lukwa","year":"2024","unstructured":"Lukwa, A. T. et al. Double burden of malnutrition among women and children in Zimbabwe: a pooled logistic regression and Oaxaca-Blinder decomposition analysis. Front. Public. Health. 12, 1451898 (2024).","journal-title":"Front. Public. Health"},{"issue":"3","key":"45173_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ecl.2023.02.001","volume":"52","author":"C Vespoli","year":"2023","unstructured":"Vespoli, C. et al. Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence. Endocrinol. Metab. Clin. North. Am. 52 (3), 417\u2013430 (2023).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"45173_CR45","doi-asserted-by":"publisher","first-page":"112956","DOI":"10.1016\/j.biopha.2022.112956","volume":"150","author":"Downregulation of hepatic","year":"2022","unstructured":"Downregulation of hepatic. fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model. Biomed. Pharmacother. 150, 112956 (2022).","journal-title":"Biomed. Pharmacother"},{"issue":"08","key":"45173_CR46","first-page":"1113","volume":"45","author":"L Lin Sulan","year":"2015","unstructured":"Lin Sulan, L. et al. Analysis of Related Risk Factors and Countermeasures in 100 Patients with Non-alcoholic Fatty Liver Disease [J]. Xinjiang Med. J. 45 (08), 1113\u20131115 (2015).","journal-title":"Xinjiang Med. J."},{"issue":"1","key":"45173_CR47","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12967-025-06490-7","volume":"23","author":"W Zhang","year":"2025","unstructured":"Zhang, W. et al. Identifying disease progression biomarkers in metabolic associated steatotic liver disease (MASLD) through weighted gene co-expression network analysis and machine learning. J. Transl Med. 23 (1), 472 (2025).","journal-title":"J. Transl Med."},{"issue":"06","key":"45173_CR48","first-page":"9","volume":"25","author":"Z Zhao Ziting","year":"2023","unstructured":"Zhao Ziting, Z. & Liu, W. Research on the Correlation between Environmental Pollutant Exposure and Non-alcoholic Fatty Liver Disease [J]. China Basic. Sci. 25 (06), 9\u201319 (2023).","journal-title":"China Basic. Sci."},{"issue":"8","key":"45173_CR49","doi-asserted-by":"publisher","first-page":"e30239","DOI":"10.2196\/30239","volume":"5","author":"V Motz","year":"2021","unstructured":"Motz, V. et al. Utilization of a Directly Supervised Telehealth-Based Exercise Training Program in Patients With Nonalcoholic Steatohepatitis: Feasibility Study. JMIR Form. Res. 5 (8), e30239 (2021).","journal-title":"JMIR Form. Res."},{"key":"45173_CR50","doi-asserted-by":"publisher","first-page":"1204285","DOI":"10.3389\/fpubh.2023.1204285","volume":"11","author":"T Yang","year":"2023","unstructured":"Yang, T. et al. The interplay of personality traits, anxiety, and depression in Chinese college students: a network analysis. Front. Public. Health. 11, 1204285 (2023).","journal-title":"Front. Public. Health"},{"issue":"3","key":"45173_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nri1571","volume":"5","author":"R Glaser","year":"2005","unstructured":"Glaser, R. & Kiecolt-Glaser, J. K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 5 (3), 243\u2013251 (2005).","journal-title":"Nat. Rev. Immunol."},{"issue":"13","key":"45173_CR52","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.3390\/jcm12134468","volume":"12","author":"M Kosmalski","year":"2023","unstructured":"Kosmalski, M. et al. The Association between Personality Factors and Metabolic Parameters among Patients with Non-Alcoholic-Fatty Liver Disease and Type 2 Diabetes Mellitus-A Cross-Sectional Study. J. Clin. Med. 12 (13), 4468 (2023).","journal-title":"J. Clin. Med."},{"issue":"06","key":"45173_CR53","first-page":"713","volume":"20","author":"P Tao Yeting","year":"2017","unstructured":"Tao Yeting, P. & Qin, C. Investigation on Personality and Emotional State of Patients with Non-alcoholic Fatty Liver Disease [J]. J. Practical Hepatol. 20 (06), 713\u2013719 (2017).","journal-title":"J. Practical Hepatol."},{"issue":"04","key":"45173_CR54","first-page":"939","volume":"37","author":"Z Liu Qiaohong","year":"2021","unstructured":"Liu Qiaohong, Z., Yu, H. & Yiyang Effects of Diet on Intestinal Microbial Flora Related to Microbiota Patterns in Non-alcoholic Fatty Liver Disease [J]. J. Clin. Hepatol. 37 (04), 939\u2013942 (2021).","journal-title":"J. Clin. Hepatol."},{"issue":"01","key":"45173_CR55","first-page":"11","volume":"41","author":"L Zhang Dan","year":"2020","unstructured":"Zhang Dan, L. et al. Establishment of Non-alcoholic Fatty Liver Disease Models through Three Different Dietary Interventions [J]. J. Kunming Med. Univ. 41 (01), 11\u201317 (2020).","journal-title":"J. Kunming Med. Univ."},{"issue":"5","key":"45173_CR56","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jhep.2021.07.025","volume":"75","author":"NF Lange","year":"2021","unstructured":"Lange, N. F., Radu, P. & Dufour, J. F. Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention. J. Hepatol. 75 (5), 1217\u20131227 (2021).","journal-title":"J. Hepatol."},{"issue":"12","key":"45173_CR57","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/s41430-021-00891-9","volume":"75","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Higher plain water intake is related to lower newly diagnosed nonalcoholic fatty liver disease risk: a population-based study. Eur. J. Clin. Nutr. 75 (12), 1801\u20131808 (2021).","journal-title":"Eur. J. Clin. Nutr."},{"issue":"1","key":"45173_CR58","doi-asserted-by":"publisher","first-page":"G155","DOI":"10.1152\/ajpgi.00325.2018","volume":"316","author":"S Nagashio","year":"2019","unstructured":"Nagashio, S. et al. Water intake increases mesenteric lymph flow and the total flux of albumin, long-chain fatty acids, and IL-22 in rats: new concept of absorption in jejunum. Am. J. Physiol. Gastrointest. Liver Physiol. 316 (1), G155\u2013G165 (2019).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"45173_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M22-1787","volume":"176","author":"CD Hansen","year":"2023","unstructured":"Hansen, C. D. et al. Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial. Ann. Intern. Med. 176 (1), 10\u201321 (2023).","journal-title":"Ann. Intern. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45173-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45173-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45173-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:01:25Z","timestamp":1774303285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45173-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45173"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45173-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol was approved by the institutional ethics committee of the Second Hospital of Hainan Medical University (2024-K57-01) and performed per Helsinki\u2019s Declaration. All participants provided written informed consent for data collection and storage.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"9551"}}